clinicalprofessionals.co.uk
Sanofi commences Phase IIb trial for Multiple Sclerosis treatment - Clinical Professionals
Sanofi annouce dosing of their first patient in a Phase IIb clinical trial being conducted to assess SAR442168 for the treatment of relapsing MS.